Marc Hafner Selected Research

Marc Hafner Research Topics

13	Neoplasms (Cancer) 02/2024 - 09/2013
10	Breast Neoplasms (Breast Cancer) 02/2024 - 09/2013
1	Weight Loss (Weight Reduction) 01/2023
1	Hypersensitivity (Allergy) 09/2022
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Ebola Hemorrhagic Fever 01/2016
1	Neoplasm Metastasis (Metastasis) 03/2014
1	Triple Negative Breast Neoplasms 03/2014
1	Huntington Disease (Huntington's Disease) 06/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2013
4	Estrogen ReceptorsIBA 02/2024 - 03/2014
2	Hormones (Hormone)IBA 02/2024 - 01/2019
2	giredestrantIBA 02/2024 - 09/2022
2	Progesterone FDA LinkGeneric 09/2022 - 03/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2019
2	LigandsIBA 03/2014 - 09/2013
1	Estrogen Receptor AntagonistsIBA 02/2024
1	AntibodiesIBA 01/2023
1	Coloring Agents (Dyes)IBA 11/2022
1	Estrogen Receptor alphaIBA 09/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	inavolisibIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Investigational DrugsIBA 01/2022
1	goblet cell silencer inhibitorIBA 01/2022
1	ribociclibIBA 01/2019
1	abemaciclibIBA 01/2019
1	palbociclibIBA 01/2019
1	Insulin-Like PeptidesIBA 01/2019
1	Insulin ReceptorIBA 01/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	kenpaulloneIBA 01/2016
1	Pharmacological BiomarkersIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2014
1	polyglutamineIBA 06/2012

4	Therapeutics 02/2024 - 09/2013